CCL2 and Hepatic fibrosis: While our preclinical study demonstrates that Bindarit-mediated Ccl2/Ccl8 inhibition attenuates liver fibrosis in Tet2ΔMye-CCl4 mice, the discordance with cenicriviroc trial outcomes underscores the challenges of clinical application of our findings.